FourKites’ Industry-First Order Intelligence Hub Extends Real-Time Visibility to the Entire Order Lifecycle
29.9.2021 12:12:00 EEST | Business Wire | Press release
FourKites® , the world’s leading real-time supply chain visibility platform, today introduced its Order Intelligence Hub, a new single-pane-of-glass view of the entire lifecycle of every order. By integrating order data, load information across modes, yard shipments, inventory visibility and other critical third-party systems, such as warehouse management systems and order management systems, shippers and their supply chain partners now have a powerful new tool to eliminate inefficiencies, manage exceptions, reduce expenses and increase customer satisfaction at every step of an order’s journey. With the goal of breaking down silos across systems, this solution was developed in close collaboration with major consumer packaged goods (CPG) customers and driven by insights from some of the largest companies in the Consumer Brand Association, which champions more than 1,700 leading CPG brands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005410/en/
FourKites’ Industry-first Order Intelligence Hub Extends Real-Time Visibility to the Entire Order Lifecycle (Graphic: Business Wire)
As part of the recently announced Supply Chain Health and Performance Task Force, the mission of which is to increase visibility and ease supply chain pressures across the CPG industry, FourKites worked closely with Consumer Brands and 15 of its members to identify common pain points and create a solution that would address those challenges by breaking down silos between teams and systems, and leveraging the scale of the FourKites network to provide unprecedented visibility into the CPG supply chain ecosystem. Through shared dashboards, participating members can take advantage of a real-time view of facilities, lanes and interchanges causing the most inefficiencies for CPG companies. With Order Intelligence Hub, users can drill down into the line-item level impacts of bottlenecks, and can then collaborate across teams to resolve those inefficiencies.
“Collaboration is essential for building modern, resilient supply chains,” said Tom Madrecki, vice president of supply chain and logistics at Consumer Brands. “The Supply Chain Health and Performance Task Force — in partnership with FourKites — is bringing more visibility, agility and data sharing to our supply chain, allowing the CPG industry to better navigate future challenges and ensure the reliable delivery of essential goods.”
By eliminating silos and integrating disparate systems, FourKites’ Order Intelligence Hub enables collaboration and insight throughout the lifecycle of every order. Teams can much more effectively manage exceptions by identifying issues and their root causes in real time, anywhere. Customisable, persona-based dashboards provide every stakeholder group — from supply planning through to customer service and facilities management — with the data and metrics that matter most to them. And the entire community benefits from FourKites‘ market-leading network data set, collected via working with more of the world’s leading brands than any other visibility provider, including 18 of the top-20 F&B brands and nine of the top-10 CPG companies.
“The Order Intelligence Hub is a big milestone as we execute on our vision to connect the physical and digital worlds of warehouses, stores and transportation with real-time data and machine learning,” said Mathew Elenjickal, founder and CEO of FourKites. “Collaborating with our customers and other industry leaders, like Consumer Brands, in product development has enabled us to bring to market some of the most innovative solutions that address the industry’s most critical pain points.”
With the Order Intelligence Hub, FourKites builds on its long history of industry-first innovations, including multimodal purchase order tracking, which provides line-item level shipment detail using PO numbers, and Dynamic Yard, which gives enterprises the ability to proactively manage all of their facilities based on real-time, in-yard freight data and analytics. FourKites and its largest customers, which ship some of the world’s leading brands to locations around the world, have integrated previously siloed systems across customer service, transportation planning, supply/demand planning and warehouse management to enable internal stakeholder communication and insights throughout the lifecycle of every order.
About FourKites
FourKites® is a leading global supply chain visibility platform, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 620 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005410/en/
Contact information
Scott Johnston
European PR Director FourKites
+31 62 147 84424
scott.johnston@fourkites.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
